| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/24/2023 | 0.46% | Morgan Stanley | $14 → $13 | Maintains | Underweight |
| 10/13/2022 | 8.19% | Morgan Stanley | $13 → $14 | Maintains | Underweight |
| 08/08/2022 | 0.46% | Morgan Stanley | $12 → $13 | Maintains | Underweight |
| 07/20/2022 | 23.65% | Goldman Sachs | → $16 | Initiates Coverage On | → Neutral |
| 07/15/2022 | -7.26% | Morgan Stanley | $13 → $12 | Maintains | Underweight |
| 04/12/2022 | 0.46% | Morgan Stanley | $12 → $13 | Maintains | Underweight |
| 02/23/2022 | -7.26% | Morgan Stanley | $10 → $12 | Maintains | Underweight |
| 02/11/2022 | 116.38% | EF Hutton | → $28 | Initiates Coverage On | → Buy |
| 11/11/2020 | -22.72% | Morgan Stanley | $8 → $10 | Maintains | Underweight |
| 06/25/2018 | — | Stifel | Terminates Coverage On | Hold → Hold | |
| 04/27/2018 | 23.65% | Stifel | $17 → $16 | Maintains | Hold |
What is the target price for Innoviva (INVA)?
There is no price target for Innoviva
What is the most recent analyst rating for Innoviva (INVA)?
There is no analyst for Innoviva
When is the next analyst rating going to be posted or updated for Innoviva (INVA)?
There is no next analyst rating for Innoviva
Is the Analyst Rating Innoviva (INVA) correct?
There is no next analyst rating for Innoviva
